Richard Adcock
CIK 1830328 · CEO & President · last filed 2026-02-24
Richard Adcock is a CEO & President who has filed 17 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for IBRX, was dated Feb 24, 2026. Across all open-market trades the lifetime net is +$17.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.99M
2
17
$17.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | CEO & President | 562,274 | $7.10 | $3.99M | $17.0K | 16 | 2026-02-24 |
| ImmunityBio, Inc. (NK) Delisted | Chief Executive Officer | 150,000 | — | — | $0 | 1 | 2021-02-09 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-24 | IBRX | Mixed | +74,879 | -$674.8K | EDGAR |
| 2026-02-12 | IBRX | Mixed | +134,074 | -$970.5K | EDGAR |
| 2026-01-05 | IBRX | Mixed | +16,973 | -$34.7K | EDGAR |
| 2025-02-25 | IBRX | Mixed | +74,272 | -$267.3K | EDGAR |
| 2025-02-12 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | IBRX | Mixed | +17,008 | -$44.7K | EDGAR |
| 2024-02-26 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2024-02-06 | IBRX | Mixed | +40,169 | -$174.4K | EDGAR |
| 2024-01-03 | IBRX | Mixed | +17,387 | -$85.8K | EDGAR |
| 2023-02-07 | IBRX | Mixed | +41,141 | -$182.7K | EDGAR |